Typical antipsychotics, also known as first-generation antipsychotics, are psychotropic medications primarily used to treat symptoms of psychosis, a mental state characterized by a loss of touch with reality and often accompanied by hallucinations and delusions. While they have been largely replaced by atypical antipsychotics in recent years, typical antipsychotics still play a significant role in managing certain mental health conditions.
Psychosis can be triggered by various psychiatric disorders and physical illnesses that affect brain function and behavior. Common mental health conditions linked to psychotic episodes include:
Common physical conditions associated with psychosis include:
Typical antipsychotics were first developed in the 1950s, and their use expanded to include conditions like acute mania, agitation, and severe mood disorders. These medications are generally divided into three potency levels: low, medium, and high.
Typical antipsychotics can cause a range of side effects, which vary depending on the specific drugs or combinations used. Some side effects may be mild and transient, while others can develop over time and potentially lead to more severe outcomes.
The most significant concern with typical antipsychotics is the risk of EPS, which affect body movement and speech. EPS can manifest in various forms, including acute dyskinesias, akathisia, and akinesia, as well as dystonic reactions and parkinsonism. In severe cases, tardive dyskinesia can develop, characterized by involuntary and repetitive facial movements.
In managing mental illness, antipsychotics are often combined with other medications, such as mood stabilizers, antidepressants, and anti-anxiety drugs, to enhance treatment effectiveness. This approach aims to target multiple symptoms and improve overall outcomes.